Drug Drug Interaction, Elderly, Emergency Department Visit, Frailty, Inappropriate Drug Use
Conditions
Keywords
emergency department, clinical pharmacists, elderly, frailty, ISAR, inappropriate prescription, Drug interaction, drug-related problems
Brief summary
The healthcare systems are under increasing pressure due to a rise in emergency consultations, staff shortages, an ageing population and rising costs. Emergency departments are seeing more vulnerable patients, including elderly people, who are often on multiple medications and at risk of medication errors. To improve safety, the integration of pharmacists specialising in emergency medicine has proven beneficial: their presence in the team improves the detection of medication-related problems, speeds up and optimises treatment, reduces rehospitalisations and lowers healthcare costs. However, in most countries, these pharmacists are still rarely found in emergency departments, mainly due to a lack of resources and clinical prioritisation criteria tailored for them and adapted to this environment. Frailty screening tools and scores, such as ISAR, can be used to identify the elderly patients most at risk, predict adverse events such as fall or mortality, and thus adapt their care in the emergency department. Indeed, elderly frail patients often take many medications and consequently are at risk of medication errors, adverse events, inappropriate prescriptions or serious drug interactions. These patients may therefore require a specialised review on their medication by clinical pharmacists when they are admitted to the emergency department, but their high number make it impossible to care for all of them. We aim thus to evaluate the association between frailty (according to the ISAR score) and medication-related problems among elderly patients admitted to the emergency department. Researchers will examine whether this score can predict the presence of inappropriate prescribing and high-risk drug interactions. If so, pharmacists would then have a quick and easy tool to prioritise patients who would benefit most from a specialised review of their medications when they visit the emergency department. There will not be any intervention and this study will not influence patients care. Once patients agree to participate, researchers will prospectively collect medical data from elderly patients admitted to the emergency department and analyse their medical history, home medication, reason for admission, frailty score using ISAR, and perform a pharmaceutical analysis based on these data.
Interventions
OTHERPharmaceutical analysis based on the Electronic Patient Record
After inclusion, each patient's data will be collected and analysed by the investigator in the following 5 days. The said data will be: * Independent variables (demographic data, laboratory results, comorbidities, home medication treatment, reason for admission) * The ISAR score, using the electronic patients record * The number of inappropriate prescriptions, using STOPP/START version 3 online tool. * The number of high-risk drug interactions (categories D Consider therapy modification and X Avoid combination), using Lexicomp™ Interact online tool. * The number of drug-related problems, using the PCNE classification version 9.1, including usual home patient's treatment as well as treatment received in the ED. * The likelihood of a medication-related emergency consultation, using AT-HARM 10 score.
Sponsors
Pharmacie des Hopitaux de l'Est Lemanique
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
75 Years to No maximum
Inclusion criteria
* Patients aged ≥ 75 years admitted to the adult emergency department * Patients able to give informed consent as documented by signature or a therapeutic representative, if applicable .
Exclusion criteria
* Patients initially admitted to the emergency resuscitation room. * Patients admitted to the minor accidents and emergencies room. * Patients admitted to the stroke unit, as they just pass through the emergency department to directly proceed to the CT-scanner. * Missing data for proper file analysis (e.g., missing usual home medication) * Patient's inability to sign consent and no therapeutic representative available * Patient's refusal to sign consent * Emergency physician's refusal to include patient for any reason.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The rate of inappropriate prescription (PIP) as a function of their ISAR score. | At the time of their admission to the emergency department | The rate of inappropriate prescription (PIP) will be compared as a function of their ISAR score, using Poisson regression analysis. PIPs will be defined according to the STOPP/START online tool version 3, developed for geriatric patients. |
| The rate of high-risk drug-drug interactions (DDIs) as a function of their ISAR score. | At the time of their admission to the emergency department | The rate of high-risk drug-drug interactions (DDIs) will be compared as a function of their ISAR score, using Poisson regression analysis. High-risk DDIs will be detected with the Lexicomp™ Interact online tool and only categories D (Consider therapy modification) and X (Avoid combination) will be considered. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The predictive performance of the ISAR score for the detection of PIPs and high-risk DDIs. | At the time of their admission to the emergency department. | Determining optimal ISAR threshold for predicting medication problems further improves its use in clinical settings. If possible, sensitivity, specificity, positive predictive value, negative predictive value, and Youden index will be calculated. |
Other
| Measure | Time frame | Description |
|---|---|---|
| The number of drug-related problems (DRPs) in function to the ISAR score. | At the time of their admission to the emergency department. | After pharmaceutical analysis of the electronic patient file, DRPs will be classified according to the Pharmaceutical Care Network Europe Association (PCNE) V9. |
| The likelihood of a medication-related emergency visit in function to the ISAR score. | At the time of their admission to the emergency department. | The likelihood of a medication-related emergency visit will be measured with the AT-HARM 10 score. This score gives a binary result (possibly or unlikely medication-related visit) and is a useful tool to exclude patients who are unlikely to be admitted due to a medication issue. |
Countries
Switzerland
Contacts
Primary ContactFerdinand Le Bloc'h, PharmD
Outcome results
None listed